PTC Therapeutics, Inc. (PTCT)

SEC filing

PTC Therapeutics, Inc.

PTCT · CIK 1070081

4 · Oct 7, 2026 · EXEC. VP AND CLO Boulding Mark Elliott sold 2,073 shares at $64.06/share ($132.8K); exercised options for 4,146 shares

EXEC. VP AND CLO Boulding Mark Elliott sold 2,073 shares at $64.06/share ($132.8K); exercised options for 4,146 shares

xslF345X06/form4-10072026_051001.xml

xslF345X06/form4-10072026_051001.xmlSEC.gov

Graphics and non-inline formats (not embedded below).